NAGLAZYME
NAGLAZYME
Approved
DIN Number
02412683
Drug Class
Human
Market Date
Jan 1, 2014
Company
HC
BIOMARIN PHARMACEUTICAL INC.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02412683
AIG Number0154752001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
A16AB08 GALSUFASE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification44:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
GALSULFASEActive
Strength: 1 MG / ML
Monograph: GALSULFASE